The association between cardiac autonomic neuropathy and heart function in type 2 diabetic patients

References

• Aune D, Schlesinger S, Neuenschwander M, Feng T, Janszky I, Norat T, Riboli E. 2018. Diabetes mellitus, blood glucose and the risk of heart failure: a systematic review and meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 28:1081–1091.
   PubMed Web of Science ®Google Scholar
• Aune D, Schlesinger S, Norat T, Riboli E. 2018. Diabetes mellitus and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 28:543–556.
   PubMed Web of Science ®Google Scholar
• Bissinger A. 2017. Cardiac autonomic neuropathy: why should cardiologists care about that? J Diabetes Res. 2017:5374176.
   PubMedGoogle Scholar
• Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. 2005. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 28:956–962.
   PubMed Web of Science ®Google Scholar
• Didangelos T, Kantartzis K. 2020. Diabetes and heart failure: is it hyperglycemia or hyperinsulinemia? Curr Vasc Pharmacol. 18:148–157.
   PubMed Web of Science ®Google Scholar
• Dimitropoulos G, Tahrani AA, Stevens MJ. 2014. Cardiac autonomic neuropathy in patients with diabetes mellitus. WJD. 5:17–39.
   Google Scholar
• Irace L, Iarussi D, Guadagno I, Tedesco MA, Perna B, Ratti G, Spadaro P, Rogliani G, Armentano V, Iacono A. 1996. Left ventricular performance and autonomic dysfunction in patients with long-term insulin-dependent diabetes mellitus. Acta Diabetol. 33:269–273.
   PubMed Web of Science ®Google Scholar
• Kazik A, Wilczek K, Poloński L. 2010. Management of diastolic heart failure. Cardiol J. 17:558–565.
   PubMed Web of Science ®Google Scholar
• Khan SS, Butler J, Gheorghiade M. 2014. Management of comorbid diabetes mellitus and worsening heart failure. JAMA. 311:2379–2380.
   PubMed Web of Science ®Google Scholar
• Kosmala W, Marwick TH. 2020. Asymptomatic left ventricular diastolic dysfunction: predicting progression to symptomatic heart failure. JACC Cardiovasc Imaging. 13:215–227.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. 2015. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 16:233–270.
   PubMed Web of Science ®Google Scholar
• Lehrke M, Marx N. 2017. Diabetes mellitus and heart failure. Am J Cardiol. 120:S37–S47.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Gerstein HC, Holman RR, Pfeffer MA. 2014. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored. Lancet Diabetes Endocrinol. 2:843–851.
   PubMed Web of Science ®Google Scholar
• Mishra TK, Rath PK, Mohanty NK, Mishra SK. 2008. Left ventricular systolic and diastolic dysfunction and their relationship with microvascular complications in normotensive, asymptomatic patients with type 2 diabetes mellitus. Indian Heart J. 60:548–553.
   PubMedGoogle Scholar
• Motataianu A, Balasa R, Voidazan S, Bajko Z. 2013. Cardiovascular autonomic neuropathy in context of other complications of type 2 diabetes mellitus. Biomed Res Int. 2013:507216.
   PubMedGoogle Scholar
• Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE. 2018. The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions. Heart Fail Rev. 23:303–323.
   PubMed Web of Science ®Google Scholar
• Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. 2000. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 102:1788–1794.
   PubMed Web of Science ®Google Scholar
• Patil VC, Patil HV, Shah KB, Vasani JD, Shetty P. 2011. Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function. J Cardiovasc Dis Res. 2:213–222.
   PubMedGoogle Scholar
• Rorth R, Jhund PS, Mogensen UM, Kristensen SL, Petrie MC, Kober L, McMurray J. 2018. Risk of incident heart failure in patients with diabetes and asymptomatic left ventricular systolic dysfunction. Dia Care. 41:1285–1291.
   PubMed Web of Science ®Google Scholar
• Sacre JW, Franjic B, Jellis CL, Jenkins C, Coombes JS, Marwick TH. 2010. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging. 3:1207–1215.
   PubMed Web of Science ®Google Scholar
• Stranieri A, Abawajy J, Kelarev A, Huda S, Chowdhury M, Jelinek HF. 2013. An approach for Ewing test selection to support the clinical assessment of cardiac autonomic neuropathy. Artif Intell Med. 58:185–193.
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, et al.; on behalf of the Toronto Diabetic Neuropathy Expert Group. 2010. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 33:2285–2293.
   PubMed Web of Science ®Google Scholar
• Vinik AI, Camacho PM, Davidson JA, Handelsman Y, Lando HM, Leddy AL, Reddy SK, Cook R, Spallone V, Tesfaye S, et al. 2017. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Testing for Autonomic and Somatic Nerve Dysfunction. Endocr Pract. 23:1472–1478.
   PubMed Web of Science ®Google Scholar
• Vinik AI, Casellini C, Parson HK, Colberg SR, Nevoret ML. 2018. Cardiac autonomic neuropathy in diabetes: a predictor of cardiometabolic events. Front Neurosci. 12:591.
   PubMed Web of Science ®Google Scholar